These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30068297)

  • 21. A Novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity.
    Kobayashi H; Ogawa Y; Shintani M; Ebihara K; Shimodahira M; Iwakura T; Hino M; Ishihara T; Ikekubo K; Kurahachi H; Nakao K
    Diabetes; 2002 Jan; 51(1):243-6. PubMed ID: 11756348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment.
    Ayers KL; Glicksberg BS; Garfield AS; Longerich S; White JA; Yang P; Du L; Chittenden TW; Gulcher JR; Roy S; Fiedorek F; Gottesdiener K; Cohen S; North KE; Schadt EE; Li SD; Chen R; Van der Ploeg LHT
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2601-2612. PubMed ID: 29726959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel melanocortin 4 receptor gene mutations in severely obese children.
    Lee YS; Poh LK; Kek BL; Loke KY
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):529-35. PubMed ID: 17941900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic screening for MC4R gene identifies three novel mutations associated with severe familiar obesity in a cohort of Spanish individuals.
    Gimeno-Ferrer F; Albuquerque D; García Banacloy A; Guzmán Luján C; Vidal Garcia C; Marcaida Benito G; Sánchez Juan C; Bruna Esteban M; Rodríguez-López R
    Gene; 2019 Jul; 704():74-79. PubMed ID: 30981838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic variant screening of MC3R and MC4R genes in early-onset obese children and their relatives among a Thai population: family-based study.
    Wannaiampikul S; Phonrat B; Tungtrongchitr A; Limwongse C; Chongviriyaphan N; Santiprabhob J; Tungtrongchitr R
    Genet Mol Res; 2015 Dec; 14(4):18090-102. PubMed ID: 26782456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.
    Farooqi IS; Keogh JM; Yeo GS; Lank EJ; Cheetham T; O'Rahilly S
    N Engl J Med; 2003 Mar; 348(12):1085-95. PubMed ID: 12646665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanocortin-4 receptor gene mutations in a Dutch cohort of obese children.
    van den Berg L; van Beekum O; Heutink P; Felius BA; van de Heijning MP; Strijbis S; van Spaendonk R; Piancatelli D; Garner KM; El Aouad R; Sistermans E; Adan RA; Delemarre-van de Waal HA
    Obesity (Silver Spring); 2011 Mar; 19(3):604-11. PubMed ID: 20966905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variants in LEP, LEPR, and MC4R explain 30% of severe obesity in children from a consanguineous population.
    Saeed S; Bonnefond A; Manzoor J; Shabbir F; Ayesha H; Philippe J; Durand E; Crouch H; Sand O; Ali M; Butt T; Rathore AW; Falchi M; Arslan M; Froguel P
    Obesity (Silver Spring); 2015 Aug; 23(8):1687-95. PubMed ID: 26179253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization.
    Biebermann H; Krude H; Elsner A; Chubanov V; Gudermann T; Grüters A
    Diabetes; 2003 Dec; 52(12):2984-8. PubMed ID: 14633860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans.
    Lubrano-Berthelier C; Le Stunff C; Bougnères P; Vaisse C
    J Clin Endocrinol Metab; 2004 May; 89(5):2028-32. PubMed ID: 15126516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of melanocortin-4 receptor gene mutations in Slovak obese children and adolescents.
    Polák E; Vitáriušová E; Celec P; Pribilincová Z; Košťálová Ľ; Hlavatá A; Kovács L; Kádaši Ľ
    J Pediatr Endocrinol Metab; 2016 Jan; 29(1):55-61. PubMed ID: 26244670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort.
    Vollbach H; Brandt S; Lahr G; Denzer C; von Schnurbein J; Debatin KM; Wabitsch M
    Int J Obes (Lond); 2017 Jan; 41(1):13-22. PubMed ID: 27654141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity.
    Miraglia Del Giudice E; Cirillo G; Nigro V; Santoro N; D'Urso L; Raimondo P; Cozzolino D; Scafato D; Perrone L
    Int J Obes Relat Metab Disord; 2002 May; 26(5):647-51. PubMed ID: 12032748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A two-base deletion -439delGC in the melanocortin-4 receptor promoter associated with early-onset obesity.
    Valli-Jaakola K; Palvimo JJ; Lipsanen-Nyman M; Salomaa V; Peltonen L; Kontula K; Schalin-Jäntti C
    Horm Res; 2006; 66(2):61-9. PubMed ID: 16710097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss-of-function mutations in MC4R are very rare in the Greek severely obese adult population.
    Rouskas K; Meyre D; Stutzmann F; Paletas K; Papazoglou D; Vatin V; Marchand M; Kouvatsi A; Froguel P
    Obesity (Silver Spring); 2012 Nov; 20(11):2278-82. PubMed ID: 22447289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Counterintuitive effects of double-heterozygous null melanocortin-4 receptor and leptin genes on diet-induced obesity and insulin resistance in C57BL/6J mice.
    Trevaskis JL; Meyer EA; Galgani JE; Butler AA
    Endocrinology; 2008 Jan; 149(1):174-84. PubMed ID: 17932216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population.
    Rong R; Tao YX; Cheung BM; Xu A; Cheung GC; Lam KS
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):198-205. PubMed ID: 16886960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A heterozygous mutation in the third transmembrane domain causes a dominant-negative effect on signalling capability of the MC4R.
    Tarnow P; Rediger A; Brumm H; Ambrugger P; Rettenbacher E; Widhalm K; Hinney A; Kleinau G; Schaefer M; Hebebrand J; Krause G; Grüters A; Biebermann H
    Obes Facts; 2008; 1(3):155-62. PubMed ID: 20054175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report.
    Iepsen EW; Have CT; Veedfald S; Madsbad S; Holst JJ; Grarup N; Pedersen O; Brandslund I; Holm JC; Hansen T; Torekov SS
    Cell Rep Med; 2020 Apr; 1(1):100006. PubMed ID: 33205056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort.
    Wade KH; Lam BYH; Melvin A; Pan W; Corbin LJ; Hughes DA; Rainbow K; Chen JH; Duckett K; Liu X; Mokrosiński J; Mörseburg A; Neaves S; Williamson A; Zhang C; Farooqi IS; Yeo GSH; Timpson NJ; O'Rahilly S
    Nat Med; 2021 Jun; 27(6):1088-1096. PubMed ID: 34045736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.